...
首页> 外文期刊>JBMR plus. >Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D?
【24h】

Is There Proof of Extraskeletal Benefits From Vitamin D Supplementation From Recent Mega Trials of Vitamin D?

机译:从维生素D的维生素D的额外补充来自维生素D的巨蛋白益处的替代药物吗?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Scientific interest in possible extraskeletal effects of vitamin D first appeared in the 1930s soon after the structure of vitamin D was characterized, and increased in the 1980s with the development of assays of 25‐hydroxyvitamin D status as a marker of vitamin D status, which in observational epidemiological studies was shown to be inversely associated with many nonskeletal diseases. This resulted in the start of seven large randomized controlled trials (n??2000 participants in each) of vitamin D supplementation giving higher doses than previously used. The intervention periods in these trials collectively started in 2009 and continued to 2020. They have recruited participants, mostly of both sexes and over the age of 50?years, from many countries and have given either daily or monthly doses of vitamin D. Collectively, the trials have a wide range of outcomes with the main focus on the prevention of cancer, cardiovascular disease, and fractures, besides many other outcomes. The findings of four trials have been published, and they have shown that vitamin D supplementation does not prevent hard‐disease endpoints, such as cardiovascular disease, cancer, fractures, or falls, aside from a possible beneficial effect against cancer mortality. In contrast, beneficial effects were seen for intermediate outcomes such as BMD of spine and hips, arterial function, and lung function, especially in people with vitamin D deficiency. The finding of a benefit primarily in people with vitamin D deficiency, if confirmed by the other trials, would support a population approach to preventing vitamin D deficiency using fortification rather than the high‐risk approach of screening for deficiency combined with supplementation. The findings on other outcomes from the three published trials, along with the findings from the four unpublished trials, are expected within the next 2 to 3?years to clarify the role of vitamin D supplementation in preventing nonskeletal disease. ? 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
机译:科学对维生素D可能的外核效果首先出现在20世纪30年代在20世纪30年代的特征在于20世纪80年代,并在20世纪80年代增加了25-羟基vitamind的测定作为维生素D状态的标志物,这在观察性流行病学研究显示与许多内骨骼疾病相反。这导致了七种大型随机对照试验的开始(N?&Δ2000参与者)维生素D补充剂的补充剂,其剂量比以前使用的剂量更高。这些试验中的干预期在2009年统称,并持续到2020年。他们招募了参与者,大多数是两岁的两年,来自许多国家,并给予每日或每月剂量的维生素D。除了许多其他成果之外,该试验具有广泛的重点,主要关注预防癌症,心血管疾病和骨折。已经发表了四次试验的结果,并且他们表明维生素D补充不会阻止难疾病终点,例如心血管疾病,癌症,骨折或跌倒,除了可能的抗癌死亡率。相比之下,对于脊柱和臀部,动脉函数和肺功能的BMD等中间结果观察有益效果,特别是在维生素D缺乏的人们中。如果通过其他试验证实,患有维生素D缺乏症的人的益处将支持人口方法,以防止维生素D使用强化缺乏缺乏症,而不是筛选缺陷的高风险方法。来自三项公布试验的其他结果的调查结果以及来自四项未发表试验的调查结果,预计在接下来的2到3日内预计会澄清维生素D补充在预防内骨骼疾病方面的作用。还2020作者。 JBMR Plus由Wiley期刊LLC发布。代表美国骨骼和矿物学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号